Catalyst Wire Dossier Catalyst Wire Dossier

Cubicin

daptomycin · Merck & Co.
Drug timelines are a Plus or Pro feature.

19 regulatory and trial events tracked for Cubicin, covering 2010-08-26 to 2026-04-14. Get the full timeline:

Most recent: Clinical Trial Update: Subcutaneous Daptomycin in Healthy Volunteers (DAPTOSC) [Phase 1]

See pricing